Prospective outcomes associated with migration from preoperative to intraoperative planned brachytherapy: A single center report

Journal of Urology

Volumn 172, Issue 6 II, 2004, Pages 2528-2531

  Woolsey, Jeffrey ^a   Bissonette, Eric ^b   Schneider, Bernard F ^a   Theodorescu, Dan ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Brachytherapy; Prostatic neoplasms

Indexed keywords

ADULT; AGED; BRACHYTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; DOSIMETRY; HUMAN; HUMAN TISSUE; IMPLANT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; OUTCOMES RESEARCH; PEROPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; QUESTIONNAIRE; SCORING SYSTEM; TIME; TUMOR VOLUME;

EID: 8644262237     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000144200.48725.e2     Document Type: Conference Paper

References (20)

1. Blasko, J. C., Grimm, P. D., Sylvester, J. E., Badiozani, K. R., Hoak, D. and Cavanaugh, W.: Palladium-103 brachytherapy for prostate carcinoma. Int J Radiat Oncol Biol Phys, 46: 839, 2000
2. Ragde, H., Elgamal, A. A., Snow, P. B., Brandt, J., Bartolucci, A. A., Nadir, B. S. et al: Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma. Cancer, 83: 989, 1998
3. Storey, M. R., Landgren, R. C., Cottone, J. L., Stallings, J. W., Logan, C. W., Fraiser, L. P. et al: Transperineal 125iodine implantation for treatment of clinically localized prostate cancer: 5-year tumor control and morbidity. Int J Radiat Oncol Biol Phys, 43: 565, 1999
4. 125iodine brachytherapy for localized prostate cancer. J Urol, 161: 1212, 1999
5. Stock, R. G., Stone, N. N., Wesson, M. F. and DeWyngaert, J. K.: A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation. Int J Radiat Oncol Biol Phys, 32: 219, 1995
6. Shanahan, T. G., Nanavati, P. J., Mueller, P. W. and Maxey, R. B.: A comparison of permanent prostate brachytherapy techniques: preplan vs. hybrid interactive planning with postimplant analysis. Int J Radiat Oncol Biol Phys, 53: 490, 2002
7. Krupski, T., Bissonette, E. A., Petroni, G. R. and Theodorescu, D.: The impact of prostate volume following neoadjuvant androgen deprivation on quality of life and voiding symptoms in patients undergoing permanent prostate brachytherapy. Eur Urol, 43: 467, 2003
8. Wallner, K., Ellis, W., Russell, K., Cavanagh, W. and Blasko, J.: Use of TRUS to predict pubic arch interference of prostate brachytherapy. Int J Radiat Oncol Biol Phys, 43: 583, 1999
9. Stone, N. N. and Stock, R. G.: Prostate brachytherapy in patients with prostate volumes >/= 50 cm(3): dosimetic analysis of implant quality. Int J Radiat Oncol Biol Phys, 46: 1199, 2000
10. Krupski, T., Petroni, G. R., Bissonette, E. A. and Theodorescu, D.: Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer. Urology, 55: 736, 2000
11. Desai, J., Stock, R. G., Stone, N. N., Iannuzzi, C. and DeWyngaert, J. K.: Acute urinary morbidity following I-125 interstitial implantation of the prostate gland. Radiat Oncol Invest, 6: 135, 1998
12. Brown, D., Colonias, A., Miller, R., Benoit, R., Cohen, J., Arshoun, Y. et al: Urinary morbidity with a modified peripheral loading technique of transperineal (125)i prostate implantation. Int J Radiat Oncol Biol Phys, 47: 353, 2000
13. Fulmer, B. R., Bissonette, E. A., Petroni, G. R. and Theodorescu, D.: Prospective assessment of voiding and sexual function after treatment for localized prostate carcinoma: comparison of radical prostatectomy to hormonobrachytherapy with and without external beam radiotherapy. Cancer, 91: 2046, 2001
14. Stock, R. G., Kao, J. and Stone, N. N.: Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer. J Urol, 165: 436, 2001
15. Merrick, G. S., Wallner, K., Butler, W. M., Lief, J. H. and Sutlief, S.: Short-term sexual function after prostate brachytherapy. Int J Cancer, 96: 313, 2001
16. Koutrouvelis, P. G., Lailas, N., Katz, S., Sehn, J., Gil-Montero, G. and Khawand, N.: Prostate cancer with large glands treated with 3-dimensional computerized tomography guided pararectal brachytherapy: up to 8 years of followup. J Urol, 169: 1331, 2003
17. D'Amico, A., Cormack, R., Kumar, S. and Tempany, C. M.: Real-time magnetic resonance imaging-guided brachytherapy in the treatment of selected patients with clinically localized prostate cancer. J Endourol, 14: 367, 2000
18. Matzkin, H., Kaver, I., Stenger, A., Agai, R., Esna, N. and Chen, J.: Iodine-125 brachytherapy for localized prostate cancer and urinary morbidity: a prospective comparison of two seed implant methods - preplanning and intraoperative planning. Urology, 62: 497, 2003
19. D'Souza, W. D., Lee, H. K., Palmer, M. B., Smith, L. G. and Pollack, A.: Is intraoperative nomogram-based overplanning of prostate implants necessary? Int J Radiat Oncol Biol Phys, 56: 462, 2003
20. Lee, E. K. and Zaider, M.: Intraoperative dynamic dose optimization in permanent prostate implants. Int J Radiat Oncol Biol Phys, 58:854, 2003